KvLQT2

ICA-069673.png

KvLQT2 is a gene that encodes the potassium voltage-gated channel subfamily Q member 2 protein, which is crucial for the proper functioning of cardiac cells. This gene is located on chromosome 7 in humans and is associated with the Long QT syndrome (LQTS), specifically type 2 (LQT2).

Function

The KvLQT2 protein is a part of the voltage-gated potassium channels, which are essential for the repolarization phase of the cardiac action potential. These channels help in maintaining the proper electrical activity of the heart by allowing potassium ions to flow out of the cardiac cells, thus contributing to the regulation of the heart's rhythm.

Clinical Significance

Mutations in the KvLQT2 gene can lead to Long QT syndrome, a condition characterized by prolonged repolarization of the heart after a heartbeat. This can result in an increased risk of arrhythmias, syncope, seizures, and sudden cardiac death. LQT2 is one of the several types of Long QT syndrome, each associated with different genetic mutations.

Diagnosis and Management

Diagnosis of LQT2 typically involves genetic testing to identify mutations in the KvLQT2 gene. Management of the condition may include lifestyle modifications, medications such as beta blockers, and in some cases, the implantation of a cardioverter-defibrillator to prevent sudden cardiac death.

Research

Ongoing research is focused on understanding the precise mechanisms by which KvLQT2 mutations lead to Long QT syndrome and developing targeted therapies to treat or manage the condition more effectively.

See Also

• Long QT syndrome
• Arrhythmia
• Cardiac action potential
• Potassium channel